We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
I am a...
Please join us in congratulating Yelak Biru, dynamic myeloma patient advocate and former Data and Analytics Exec at PepsiCo and Walmart, on his new role as CEO of the IMF. Welcome aboard! Click on the image to read the full press release.
This week, the promise of major progress in our understanding of myeloma from research at ASH this year coincided with concerning news of a new COVID-19 variant. IMF Chairman Dr. Brian G.M. Durie examines both.
On November 4, the International Myeloma Foundation (IMF) announced that data from the IMF-supported iStopMM study will be showcased in four oral presentations at the 63rd American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia, December 11-14. Serum samples from more than 75,000 individuals are enabling the study’s Iceland-based research team to shed much-needed light on the early development of myeloma, a cancer of the bone marrow plasma cells, and consider the potential benefits of early screening for MGUS, myeloma’s precursor condition. Click the image to read the full press release.
Stay tuned as the International Myeloma Foundation (IMF) brings together myeloma support group leaders and patients to the virtual 63rd annual meeting and expo of the American Society of Hematology (ASH) from December 11-14, 2021. The 63rd ASH Annual Meeting and Exposition will be an exciting convergence of 20,000 healthcare professionals from across the globe. Follow the IMF ASH team members at the link below. Their blogs will go live in a week. Remember to bookmark the page in your preferred browser.
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
Last year marks the International Myeloma Foundation's (IMF) 30th anniversary, celebrating 30 years of scientific achievement with myeloma patient care at the heart of it all. What started in a garage with a borrowed typewriter is now the largest organization focused specifically on multiple myeloma. The IMF continues to push the needle forward toward a cure for myeloma with cure-focused trials and over 40 active research projects around the world. As IMF President and Founder Susie Durie says, "We are this close to the cure. I can see it on the horizon."
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
